Abstract:The histamine H4 receptor (H4R) was first noted as a sequence in genomic databases that had features of a class A G-protein coupled receptor. This putative receptor was found to bind histamine consistent with its homology to other histamine receptors and thus became the fourth member of the histamine receptor family. Due to the previous success of drugs that target the H1 and H2 receptors, an effort was made to understand the function of this new receptor and determine if it represented a viable drug target. Taking advantage of the vast literature on the function of histamine, a search for histamine activity that did not appear to be mediated by the other three histamine receptors was undertaken. From this asthma and pruritus emerged as areas of particular interest. Histamine has long been suspected to play a role in the pathogenesis of asthma, but antihistamines that target the H1 and H2 receptors have not been shown to be effective for this condition. The use of selective ligands in animal models of asthma has now potentially filled this gap by showing a role for the H4R in mediating lung function and inflammation. A similar story exists for chronic pruritus associated with conditions such as atopic dermatitis. Antihistamines that target the H1 receptor are effective in reducing acute pruritus, but are ineffective in pruritus experienced by patients with atopic dermatitis. As for asthma, animal models have now suggested a role for the H4R in mediating pruritic responses, with antagonists of the H4R reducing pruritus in a number of different conditions. The anti-pruritic effect of H4R antagonists has recently been shown in human clinical studies, validating the preclinical findings in the animal models. A selective H4R antagonist inhibited histamine-induced pruritus in health volunteers and reduced pruritus in patients with atopic dermatitis. The history to date of the H4R provides an excellent example of the deorphanization of a novel receptor and the translation of this into clinical efficacy in humans.

A Novel Histamine Receptor:Histamine H4 Receptor

Histamine receptors, agonists, and antagonists in health and disease

Pharmacological characterization of seven human histamine H3 receptor isoforms

Structural basis of ligand recognition and design of antihistamines targeting histamine H4 receptor

Identification of TSPAN4 as Novel Histamine H4 Receptor Interactor

Label-free cell phenotypic profiling of histamine H4R receptor and discovery of non-competitive H4R antagonist from natural products

The histamine H4 receptor: from orphan to the clinic

Update on Histamine and Antihistamines

Docking and MD Study of Histamine H4R Based on the Crystal Structure of H1R

Histamine pharmacology: from Sir Henry Dale to the 21st century

Structural basis of ligand recognition and activation of the histamine receptor family

The 3D-QSAR Model Analysis of Histamine H4 Receptor Ligands

Structural Basis for Recognition of Antihistamine Drug by Human Histamine Receptor

Different antagonist binding properties of human and rat histamine H3 receptors

Identification and Characterization of ZEL-H16 As a Novel Agonist of the Histamine H3 Receptor.

Integrative genomic analyses of the histamine H1 receptor and its role in cancer prediction

Novel Heterocyclic-Substituted Benzofuran Histamine H-3 Receptor Antagonists: in Vitro Properties, Drug-Likeness, and Behavioral Activity

The Function of the Histamine H4 Receptor in Inflammatory and Inflammation-Associated Diseases of the Gut

Computational investigation of interactions between human H2 receptor and its agonists.

Classification and biological distribution of histamine receptor sub-types

Histamine H 1 and H 2 Receptor Gene and Protein Levels Are Differentially Expressed in the Hearts of Rodents and Humans